These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recognized molecular mechanisms of heart failure: approaches to treatment. Ceconi C; Cargnoni A; Curello S; Ferrari R Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of cardiac dysfunction in congestive heart failure. Dhalla NS; Afzal N; Beamish RE; Naimark B; Takeda N; Nagano M Can J Cardiol; 1993 Dec; 9(10):873-87. PubMed ID: 8281476 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological therapeutics based on molecular mechanisms]. Akazawa H; Komuro I Nihon Rinsho; 2006 May; 64(5):897-903. PubMed ID: 16689371 [TBL] [Abstract][Full Text] [Related]
7. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Morgan JP; Erny RE; Allen PD; Grossman W; Gwathmey JK Circulation; 1990 Feb; 81(2 Suppl):III21-32. PubMed ID: 2153479 [TBL] [Abstract][Full Text] [Related]
8. Heart failure and Starling's Law of the heart. ter Keurs HE Can J Cardiol; 1996 Oct; 12(10):1047-57. PubMed ID: 9191498 [TBL] [Abstract][Full Text] [Related]
9. The identification of contributory mechanisms for the development and progression of congestive heart failure in animal models. Iannini JP; Spinale FG J Heart Lung Transplant; 1996 Nov; 15(11):1138-50. PubMed ID: 8956123 [TBL] [Abstract][Full Text] [Related]
10. When calcium turns arrhythmogenic: intracellular calcium handling during the development of hypertrophy and heart failure. Zaugg CE; Buser PT Croat Med J; 2001 Feb; 42(1):24-32. PubMed ID: 11172652 [TBL] [Abstract][Full Text] [Related]
11. Metabolic disarrangement in ischemic heart disease and its therapeutic control. Ferrari R Rev Port Cardiol; 1998 Sep; 17(9):667-84. PubMed ID: 9834638 [TBL] [Abstract][Full Text] [Related]
12. Gene therapy targeted at calcium handling as an approach to the treatment of heart failure. Hoshijima M Pharmacol Ther; 2005 Mar; 105(3):211-28. PubMed ID: 15737405 [TBL] [Abstract][Full Text] [Related]
16. Reversal of calcium cycling defects in advanced heart failure toward molecular therapy. Hoshijima M; Knöll R; Pashmforoush M; Chien KR J Am Coll Cardiol; 2006 Nov; 48(9 Suppl 1):A15-23. PubMed ID: 17084280 [TBL] [Abstract][Full Text] [Related]
17. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure. Scolletta S; Biagioli B Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925 [TBL] [Abstract][Full Text] [Related]
18. Cardiac remodeling and failure: from molecules to man (Part I). Fedak PW; Verma S; Weisel RD; Li RK Cardiovasc Pathol; 2005; 14(1):1-11. PubMed ID: 15710285 [TBL] [Abstract][Full Text] [Related]